Viatris Says Late-breaking Oral Presentation Shows That Cenerimod For Systemic Lupus Erythematosus In Japanese Patients Can Be Considered Safe And Well-tolerated
Viatris Says Late-breaking Oral Presentation Shows That Cenerimod For Systemic Lupus Erythematosus In Japanese Patients Can Be Considered Safe And Well-tolerated
維阿特公司表示，晚期口服報告表明Cenerimod用於日本患者的系統性紅斑狼瘡是安全且耐受良好的。
The ACT-333441 study was accepted as a late-breaking abstract and was presented during an oral presentation at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress. The congress is being held August 21-25, 2024, in Suntec, Singapore.
ACt-333441研究作爲一份晚期摘要被接受，並在第26屆亞太類風溼病學聯盟(APLAR)年會的口頭報告中展示。該年會將於2024年8月21日至25日在新加坡聖淘沙舉行。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。